PC
Polar Capital Portfolio holdings
AUM
$13.5B
This Quarter Return
+8.75%
1 Year Return
+55.85%
3 Year Return
+125.38%
5 Year Return
+259.12%
10 Year Return
–
AUM
$5.52B
AUM Growth
+$5.52B
(+12%)
Cap. Flow
+$181M
Cap. Flow
% of AUM
3.28%
Top 10 Holdings %
Top 10 Hldgs %
22.93%
Holding
313
New
33
Increased
112
Reduced
68
Closed
58
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$98.9M |
| 2 |
Johnson & Johnson
JNJ
|
$96.4M |
| 3 |
Microsoft
MSFT
|
$46.2M |
| 4 |
Bristol-Myers Squibb
BMY
|
$37M |
| 5 |
Boston Scientific
BSX
|
$34.7M |
Top Sells
| 1 |
Pfizer
PFE
|
$75.3M |
| 2 |
Alphabet (Google) Class C
GOOG
|
$62.3M |
| 3 |
Wells Fargo
WFC
|
$36.6M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
$32.1M |
| 5 |
Comcast
CMCSA
|
$31.3M |
Sector Composition
| 1 | Healthcare | 24.6% |
| 2 | Technology | 23.7% |
| 3 | Financials | 21.11% |
| 4 | Communication Services | 10.58% |
| 5 | Consumer Discretionary | 6.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Alphabet (Google) Class C
GOOG
$2.58T
| $207M | 3.74% | 272,790 -82,104 | -23% | -$62.3M |
|
2
Apple
AAPL
$3.45T
| $183M | 3.31% | 1,740,830 -197,340 | -10% | -$20.8M |
|
|
3
Johnson & Johnson
JNJ
$427B
| $175M | 3.16% | 1,699,042 +938,624 | +123% | +$96.4M |
|
4
Chubb
CB
$110B
| $125M | 2.26% | 1,071,689 +199,415 | +23% | +$23.3M |
|
|
5
Microsoft
MSFT
$3.77T
| $116M | 2.1% | 2,090,195 +832,757 | +66% | +$46.2M |
|
|
6
Alphabet (Google) Class A
GOOGL
$2.57T
| $98.9M | 1.79% | +127,071 | New | +$98.9M |
|
7
Meta Platforms (Facebook)
META
$1.86T
| $97.9M | 1.77% | 935,390 -29,807 | -3% | -$3.12M |
|
|
8
Pfizer
PFE
$141B
| $88.2M | 1.6% | 2,733,244 -2,331,604 | -46% | -$75.3M |
|
9
Medtronic
MDT
$119B
| $88.1M | 1.59% | 1,145,076 -12,916 | -1% | -$993K |
|
10
Intel
INTC
$107B
| $86.4M | 1.56% | 2,509,350 +414,411 | +20% | +$14.3M |
|
11
Markel Group
MKL
$24.8B
| $85M | 1.54% | 96,226 +11,662 | +14% | +$10.3M |
|
12
Visa
V
$683B
| $83.3M | 1.51% | 1,074,415 +114,236 | +12% | +$8.86M |
|
13
Arch Capital
ACGL
$34.2B
| $82.2M | 1.49% | 1,178,570 +41,638 | +4% | +$2.9M |
|
14
Accenture
ACN
$162B
| $78.8M | 1.43% | 754,278 +133,694 | +22% | +$14M |
|
15
Eli Lilly
LLY
$657B
| $70.3M | 1.27% | 835,000 +29,047 | +4% | +$2.45M |
|
16
Citigroup
C
$178B
| $70.3M | 1.27% | 1,358,786 +279,873 | +26% | +$14.5M |
|
17
JPMorgan Chase
JPM
$829B
| $67.3M | 1.22% | 1,018,559 -56,271 | -5% | -$3.72M |
|
18
Carnival Corp
CCL
$43.2B
| $67.1M | 1.21% | 1,232,072 +242,236 | +24% | +$13.2M |
|
|
VR
19
DELISTED
Validus Hold Ltd
VR
| $64.7M | 1.17% | 1,397,553 +397,430 | +40% | +$18.4M |
|
20
Elevance Health
ELV
$71.8B
| $64.3M | 1.16% | 461,312 +131,128 | +40% | +$18.3M |
|
|
QVCGA
21
QVC Group, Inc. Series A Common Stock
QVCGA
$69.2M
| $61.9M | 1.12% | 2,267,114 +311,694 | +16% | +$8.52M |
|
22
Fidelity National Information Services
FIS
$36.5B
| $59.9M | 1.08% | 988,219 +299,625 | +44% | +$18.2M |
|
23
Berkshire Hathaway Class B
BRK.B
$1.09T
| $58.2M | 1.05% | 440,780 +256,817 | +140% | +$33.9M |
|
24
Booz Allen Hamilton
BAH
$13.4B
| $56.6M | 1.02% | 1,835,928 -101,155 | -5% | -$3.12M |
|
25
PepsiCo
PEP
$204B
| $56.5M | 1.02% | 565,185 +30,996 | +6% | +$3.1M |
|